As shown in Figure 7, although DYRK1A was found to have a low expression in CRC compared to normal tissues, cancer samples with high DYRK1A expression were found to be enriched in late metastasis and lymph node stage (Figure 7a,b). This evidence concerns the gene DYRK1A and cancer.